NCT05960786 - Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand | Biotech Hunter

Enrollment

109

Participants

Timeline

Start Date

February 2, 2023

Primary Completion Date

December 7, 2023

Study Completion Date

December 7, 2023

Conditions

VertigoBPPVMeniere DiseaseLabrynthitisVestibular DisorderVestibular MigraineBenign Paroxysmal Positional VertigoMénière's VertigoMigraine Associated VertigoUncompensated Unilateral Vestibulopathy

Interventions

DEVICE

Otoband Experimental

Participants will be randomly assigned to use the Otoband to determine effectiveness in providing temporary relief to symptoms of vertigo.

DEVICE

Otoband Sham

Participants will be randomly assigned to use the Otoband sham to determine effectiveness in providing temporary relief to symptoms of vertigo.

Trial Locations (1)

20001

Otolith Labs, Washington D.C.